12.36BMarket Cap
249.99P/E TTM
Corcept Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Corcept Therapeutics Inc is 7.17, ranking 120 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 249.99, which is 3.35% below the recent high of 258.35 and 92.26% above the recent low of 19.35.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.